News and Announcements
Vertically Integrated Supplier of Clinically Dosed Nutritional Supplements Targeting $20B Market
- Published August 09, 2021 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
“As competitive bodybuilders, athletes, and scientists, our team understands what it takes to get results. Armed with deep expertise, we are here to help customers become successful through our proprietary range of clinically dosed nutritional supplements that target informed customers.
We believe that high-value products need supportive distribution and marketing, and that discounting can damage brand value in the long term. Inception Labs’ vertically integrated business model and strong relationships with a global manufacturer and retailers protect brand value and return on investment.
Our experience in consumer behaviour and digital commercial activity underpins our online growth, supporting or supplanting shopfronts over time.”
Matt Walley, Director, Inception Labs
Executive Summary
Inception Labs is the only source of clinically dosed nutritional supplements in Australasia with a vertically integrated business model that controls formulation, manufacturing, distribution, and retail. The company has partnered with global manufacturer ATP Science to develop its proprietary range of science-based nutritional supplements. In addition, it has a strong network of retailers and extensive social influence generated from its team of recognised athletes and personalities.
Nutritional supplements are FMCG products used by regular gym-goers and consumers who care about their health, wellbeing, and fitness. The global market for nutritional supplements is currently worth $20B and has grown by 8-9% since 2010.
Investment Highlights
- The global market for nutritional supplements is now worth $20B.
- The company has a track record in retail (5 years) and distribution (3 years) in New Zealand.
- $4-6m ARR projected in 2021.
- Profit margins on key brands have doubled from 23% to 48%.
Investment Offering
Inception Labs is raising $5M for up to 26% equity.
Company Updates
The asset class where the market has no vote
Litigation funding returns are decided in a courtroom, not a cycle. Knightsbridge’s Head of Capital is careful to call that a different risk rather than a lower one, and his answer to it is spread, not concentration. Most alternative assets still answer to something. Property answers to rates. Private credit answers to defaults. Even the […]
The listing fee vendors pay whether the house sells or not
Australia’s property portals collect more than $2 billion a year while national listings sit flat. An Australian-built AI platform is targeting the economics, not just the interface. An Australian vendor listing a home pays a vendor-paid advertising fee on top of agency commission. Rama Dwarapudi, Founder and Chief Executive Officer of RealSearch, puts a typical […]
Reinventing the Condom: How an Australian Deep-Tech Startup Plans to Disrupt a $12 Billion Market
For more than half a century, the global condom industry has remained fundamentally unchanged, constrained by standard materials like latex and solid synthetic polymers. Despite widespread consumer demand for better alternatives, product design has treated the device strictly as a mechanical barrier, sacrificing feel for function. Sydney-based Eudaemon Technologies is setting out to upend that […]
Backed By Leading Investment Groups and Family Offices
